• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别与胆结石病

Gender and gallstone disease.

作者信息

Novacek Gottfried

机构信息

Department of Internal Medicine IV, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

出版信息

Wien Med Wochenschr. 2006 Oct;156(19-20):527-33. doi: 10.1007/s10354-006-0346-x.

DOI:10.1007/s10354-006-0346-x
PMID:17103289
Abstract

Gallstone disease is a common disorder all over the world. In the Western societies about 80 % of the gallstones are composed primarily of cholesterol. Several risk factors for gallstone formation have been identified. One of the most important risk factors is female gender. Rates of gallstones are two to three times higher among women than men. But this is primarily a phenomenon of the childbearing age. Pregnancy is also a major risk factor for gallstone formation. The risk is related to the number of pregnancies. Sex hormones are most likely to be responsible for the increased risk. Estrogen increases biliary cholesterol secretion causing cholesterol supersaturation of bile. Thus, hormone replacement therapy in postmenopausal women and oral contraceptives have also been described to be associated with an increased risk for gallstone disease. However, the effect of estrogen is dose-dependent and new oral contraceptives with a low estrogen dose do not seem to increase the rate of gallstone formation. The present article focuses on the mentioned risk factors associated with female sex hormones.

摘要

胆结石病是一种全球常见的病症。在西方社会,约80%的胆结石主要由胆固醇构成。已确定了几个胆结石形成的风险因素。其中最重要的风险因素之一是女性性别。女性胆结石发病率比男性高两到三倍。但这主要是育龄期的现象。怀孕也是胆结石形成的一个主要风险因素。风险与怀孕次数有关。性激素很可能是风险增加的原因。雌激素会增加胆汁中胆固醇的分泌,导致胆汁中胆固醇过饱和。因此,绝经后女性的激素替代疗法和口服避孕药也被认为与胆结石病风险增加有关。然而,雌激素的作用是剂量依赖性的,低雌激素剂量的新型口服避孕药似乎不会增加胆结石形成的几率。本文重点关注上述与女性性激素相关的风险因素。

相似文献

1
Gender and gallstone disease.性别与胆结石病
Wien Med Wochenschr. 2006 Oct;156(19-20):527-33. doi: 10.1007/s10354-006-0346-x.
2
New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.雌激素对胆固醇结石形成影响的分子机制新见解。
Biochim Biophys Acta. 2009 Nov;1791(11):1037-47. doi: 10.1016/j.bbalip.2009.06.006. Epub 2009 Jul 6.
3
Oral contraceptives in gall stone diseases.胆结石疾病中的口服避孕药
Mymensingh Med J. 2007 Jul;16(2 Suppl):S40-45.
4
Gall-stones and oral contraceptives.
J Int Med Res. 1975;3(2):59-62. doi: 10.1177/030006057500300201.
5
The effect of chronic estrogen application on bile and gallstone composition in women with cholelithiasis.长期应用雌激素对胆石症女性胆汁及胆石成分的影响。
Minerva Endocrinol. 2016 Mar;41(1):19-27. Epub 2014 Nov 21.
6
Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians.在患有胆结石的智利西班牙裔人群以及胆结石高危马普切印第安人群中,胆汁酸合成增加。
Gastroenterology. 2004 Mar;126(3):741-8. doi: 10.1053/j.gastro.2003.12.009.
7
Risk factors associated with gallstone and biliary sludge formation during pregnancy.孕期胆结石和胆泥形成的相关危险因素。
J Gastroenterol Hepatol. 2006 Jul;21(7):1150-3. doi: 10.1111/j.1440-1746.2006.04444.x.
8
Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.已知的风险因素无法解释丹麦和德国东北部胆结石患病率的差异。
Am J Gastroenterol. 2009 Jan;104(1):89-95. doi: 10.1038/ajg.2008.13.
9
Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.经皮雌激素与口服雌激素对绝经后妇女胆结石形成的胆汁标志物影响的比较。
J Clin Endocrinol Metab. 1998 Feb;83(2):410-4. doi: 10.1210/jcem.83.2.4596.
10
Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.绝经后雌激素治疗与胆囊疾病风险:基于人群的病例对照研究。
Drug Saf. 2013 Dec;36(12):1189-97. doi: 10.1007/s40264-013-0118-7.

引用本文的文献

1
Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113.接受吉西他滨为主化疗的胆道癌患者按原发部位比较临床特征:JCOG1113的探索性分析
Int J Clin Oncol. 2025 Jul 24. doi: 10.1007/s10147-025-02834-x.
2
Association between various insulin resistance surrogates and gallstone disease based on national health and nutrition examination survey.基于国家健康与营养检查调查的各种胰岛素抵抗替代指标与胆结石疾病之间的关联。
Sci Rep. 2025 Jul 16;15(1):25877. doi: 10.1038/s41598-025-09482-1.
3
Genetics of Gallstones.

本文引用的文献

1
The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US.疑似胆源性胰腺炎中胆管结石的检测:磁共振胰胆管造影(MRCP)、内镜逆行胰胆管造影(ERCP)及胆管内超声检查的比较
Am J Gastroenterol. 2005 May;100(5):1051-7. doi: 10.1111/j.1572-0241.2005.41057.x.
2
Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence.在胆结石患病率较高地区,胆结石形成的独立危险因素。
Digestion. 2005;71(2):97-105. doi: 10.1159/000084525. Epub 2005 Mar 16.
3
Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs.
胆结石的遗传学
Genes (Basel). 2025 Feb 22;16(3):256. doi: 10.3390/genes16030256.
4
Quantification of serovar Typhimurium population dynamics in murine infection using a highly diverse barcoded library.使用高度多样化的条形码文库对鼠伤寒沙门氏菌在小鼠感染中的种群动态进行定量分析。
Elife. 2025 Feb 13;13:RP101388. doi: 10.7554/eLife.101388.
5
Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".解析高尔基蛋白73-骨桥蛋白-ATP结合盒转运体G5轴在代谢相关脂肪性肝病中的作用:关于“高尔基蛋白73通过ABCG5介导的代谢相关脂肪性肝病肝脏胆固醇流出促进胆固醇胆结石形成”的述评
Clin Mol Hepatol. 2025 Apr;31(2):628-630. doi: 10.3350/cmh.2025.0036. Epub 2025 Jan 16.
6
Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance.帕西瑞肽治疗肢端肥大症安全性的真实世界数据:来自欧洲药物警戒系统的见解
Pharmaceuticals (Basel). 2024 Dec 4;17(12):1631. doi: 10.3390/ph17121631.
7
Prevalence of gallstone disease in Africa: a systematic review and meta-analysis.非洲胆结石疾病的患病率:一项系统评价与荟萃分析。
BMJ Open Gastroenterol. 2025 Jan 4;12(1):e001441. doi: 10.1136/bmjgast-2024-001441.
8
Gender-Affirming Hormone Therapy With Estrogen Causing Gallstone Associated Acute Pancreatitis.使用雌激素的性别肯定激素疗法导致胆结石相关性急性胰腺炎。
AACE Clin Case Rep. 2024 Jul 22;10(5):210-213. doi: 10.1016/j.aace.2024.07.006. eCollection 2024 Sep-Oct.
9
Association between triglyceride-glucose index and gallstones: a cross-sectional study.甘油三酯-葡萄糖指数与胆结石之间的关联:一项横断面研究。
Sci Rep. 2024 Aug 1;14(1):17778. doi: 10.1038/s41598-024-68841-6.
10
Quantification of serovar Typhimurium Population Dynamics in Murine Infection Using a Highly Diverse Barcoded Library.使用高度多样化的条形码文库对鼠伤寒沙门氏菌在小鼠感染中的种群动态进行定量分析。
bioRxiv. 2024 Dec 11:2024.06.28.601246. doi: 10.1101/2024.06.28.601246.
遗传和环境因素对症状性胆结石疾病的影响:一项对43141对瑞典双胞胎的研究
Hepatology. 2005 May;41(5):1138-43. doi: 10.1002/hep.20654.
4
Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy.孕期胆泥和胆结石的发病率、自然史及危险因素。
Hepatology. 2005 Feb;41(2):359-65. doi: 10.1002/hep.20534.
5
Effect of estrogen therapy on gallbladder disease.雌激素疗法对胆囊疾病的影响。
JAMA. 2005 Jan 19;293(3):330-9. doi: 10.1001/jama.293.3.330.
6
Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones.雌激素受体α而非β在17β - 雌二醇诱导的小鼠胆固醇胆结石形成中起主要作用。
Gastroenterology. 2004 Jul;127(1):239-49. doi: 10.1053/j.gastro.2004.03.059.
7
Development of symptoms and complications in individuals with asymptomatic gallstones.无症状胆结石患者症状及并发症的发展情况。
Br J Surg. 2004 Jun;91(6):734-8. doi: 10.1002/bjs.4547.
8
Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients.胆固醇结石和色素结石患者中的胆汁成核蛋白与载脂蛋白E
J Hepatol. 2003 Jul;39(1):7-11. doi: 10.1016/s0168-8278(03)00177-6.
9
Age-related changes in the chemical composition of gallstones.胆结石化学成分的年龄相关性变化。
Int J Surg Investig. 2000;2(4):299-307.
10
Pathogenesis of pigment gallstones in Western societies: the central role of bacteria.西方社会色素胆结石的发病机制:细菌的核心作用。
J Gastrointest Surg. 2002 Nov-Dec;6(6):891-903; discussion 903-4. doi: 10.1016/s1091-255x(02)00035-5.